The EupAL foundation started in May 2020. EupAL aims to cure all children with acute leukemia. A particular focus is the acute myeloid leukemia (AML). A comprehensive program including basic, translational and clinical research, improve diagnostics, global integration of retrospective data, late effects and outreach programs should improve survival.
The EupAL Foundation has a joint venture with the LeukemiaLymphoma Society PedAL Initiaive. Based on execellent research, new and inovative treatment options will be offered to children and adolescents with relapsed/refractory AML.